Invictus MD closes $25 million bought deal private placement

May 24, 2017

On May 24, 2017, Invictus MD Strategies Corp. (TSXV: IMH; OTC: IVITF; FRA: 8IS) announced that it had closed its previously announced bought deal private placement, with the underwriters Canaccord Genuity Corp., Eventus Capital Corp., Echelon Wealth Partners Inc., GMP Securities L.P. and PI Financial Corp., including the over-allotment option, for aggregate gross proceeds of $25,008,750. A total of 18,525,000 units, including those pursuant to the exercise of the over-allotment option, were issued at a price of $1.35 per unit.

Invictus MD Strategies Corp. is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR including investment in the fully licensed facilities operated by AB Laboratories Inc. and Acreage Pharms Ltd.; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd.

Miller Thomson advised the underwriters in this transaction with a team that included Dwight Dee, Peter McArthur, Erika Lai and Blair Lowther (securities) and Lisa Sim (IP).